Insuline resistance treatment effect in patients with genotype 1 hepatitis C treated with peginterferon alfa-2a plus ribavirin in usual clinical practiceEfecto del tratamiento de la resistencia a insulina en los pacientes con hepatitis C crónica genotipo 1 tratados con peginterferón alfa-2a en combinación con ribavirina en la práctica clínica habitual - Insuline resistance treatment effect in genotype 1 hepatitis C treated with Peg-IFN alfa 2a & RBV
- Conditions
- Treatment effect of insuline resistance in patients with genotype 1 hepatitis C treated with peginterferon alfa 2a plus ribavirin in usual clinical practice
- Registration Number
- EUCTR2005-002446-19-ES
- Lead Sponsor
- Hospital de Valme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method